Insights from the Best of ASCO 2024 Miami by Estela Rodriguez
The Best of ASCO 2024 Miami Symposium was a summarized version of the ASCO Annual Conference made available locally to simulate attendance for those who may not have the resources or time to attend the national conference.
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead of the Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center, shared her highlights from the Best of ASCO 2024 session.
EGFR intensification strategies and perioperative IO outcomes:
Great representation from Spanish thoracic oncology colleagues at Best of ASCO in Miami discussing new data on EGFR intensification strategies and perioperative IO outcomes.
History of perioperative chemoIO trials in lung cancer:
What a treat to have Professor Mariano Provencio (NADIM trial) at Best of ASCO 2024 Miami presenting history of perioperative chemoIO trials in lung cancer and what we have learned so far: most of patients with pCR are disease free at 3 yr (regardless of N2, PDL1) surgery outcomes not impacted.
Feasibility of ctDNA MRD monitoring in lung cancer:
Dr Ignacio Gil Bazo gives a fascinating overview of feasibility of ctDNA MRD monitoring in lung cancer based on recent adjuvant and perioperative chemoIO trials have we moved beyond proof of concept and ready to use MRD monitoring?
Faculty dinner at Best of ASCO:
Great faculty dinner last night at Best of ASCO 2024 in Miami. With Edgardo S. Santos, Nagla Abdel Karim, Luis E. Raez and Kashyap Patel.
For more coverage on ASCO24, visit oncodaily.com